Startseite>>Signaling Pathways>> Others>> Synthases/Synthetases>>1-Benzylimidazole

1-Benzylimidazole

Katalog-Nr.GC17678

selective inhibitor of thromboxane synthase

Products are for research use only. Not for human use. We do not sell to patients.

1-Benzylimidazole Chemische Struktur

Cas No.: 4238-71-5

Größe Preis Lagerbestand Menge
5g
33,00 $
Auf Lager
25g
126,00 $
Auf Lager
100g
428,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Benzylimidazole is a selective inhibitor of thromboxane synthase and a stimulator of UDP-glucuronosyltransferase [1,2].

Thromboxane synthase is a cytochrome P450 enzyme. The cytochrome P450 proteins have been involved in catalyzing many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids. The enzyme plays an important role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. The gene expresses two transcript variants [3].

1-Benzylimidazole selectively inhibited the activity of thromboxane synthase. 1-Benzylimidazole reduced TXB2 levels and increased blood flow in ischemia-reperfusion injury of rat brain [1]. In male Wistar rats, gastrically administration of 1-benzylimidazole (25, 75 and 100 mg/kg/day) caused a dose-dependent hepatomegaly. 1-Benzylimidazole decreased the plasma level in triglycerides by 60–70%. 1-benzylimidazole stimulated three distinct forms of UDP-glucuronosyltransferase. 1-benzylimidazole significantly increased the activities towards 4-methylumbelliierone, 1-naphthol, morphine or a monoterpenoid alcohol, nopol [2]. Benzylimidazole increased hepatocellular CYP1A catalytic activity and CYP1A mRNA in a concentration-dependent way [4].

References:
[1] Pettigrew L C, Grotta J C, Rhoades H M, et al.  Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain[J]. Stroke, 1989, 20(5): 627-632
[2]. Magdalou J, Totis M, Boiteux-Antoine A F, et al. Effect of 1-benzylimidazole on cytochromes P-450 induction and on the activities of epoxide hydrolases and UDP-glucuronosyltransferases in rat liver[J]. Biochemical pharmacology, 1988, 37(17): 3297-3304.
Shen R F, Tai H H.  Thromboxanes: synthase and receptors[J]. Journal of biomedical science, 1998, 5(3): 153-172.
[3] Shen R F, Tai H H.  Thromboxanes: synthase and receptors[J]. Journal of biomedical science, 1998, 5(3): 153-172.
[4] Navas J M, Chana A, Herradón B, et al.  Induction of CYP1A by the N‐imidazole derivative, 1‐benzylimidazole[J]. Environmental toxicology and chemistry, 2003, 22(4): 830-836.

Bewertungen

Review for 1-Benzylimidazole

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-Benzylimidazole

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.